Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Clinical trial NCT04926194 · COMPLETED

Trial details

NCT number: NCT04926194
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic/Myeloproliferative Neoplasm Steroid Refractory GVHD Allogeneic Hematopoietic Cell Transplant

Start date: 2021-03-11
Primary completion: 2021-06-09
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.